Physicians

Survey finds doctors ok with working for others

Survey finds doctors ok with working for others

By

A recent Medscape survey found that under-40s were more likely to work for a healthcare organization than were their older colleagues, trading autonomy for work-life balance and income predictability.

Medscape finds docs are a lot like their patients

Medscape finds docs are a lot like their patients

By

The third lifestyle survey shows that doctors are battling the bulge just like everyone else.

Poll: Statin use will grow modestly

Poll: Statin use will grow modestly

By

A poll indicates new cholesterol guidelines won't shake up the statin market in 2014.

E-prescribing systems not so pharma friendly

E-prescribing systems not so pharma friendly

By

A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.

Rebound seen in HCP meeting turnout: report

Rebound seen in HCP meeting turnout: report

By

Attendance by physicians crept up in 2012, said the trade group HCEA, but overall turnout was flat, likely because exhibitors brought less personnel along to meetings.

Intouch creates HCP content division

Intouch creates HCP content division

By

Growing client demand encouraged the agency to make its HCP content capabilities official.

NPs, PAs avoiding primary care, while docs glum about independent practices

By

Researchers say we've been overestimating how many NPs and PAs can be expected to ease the inflow of just-insured patients, while another study shows just why they may be bypassing independent practices.

Good day, Sunshine: Tools help docs track payments

Good day, Sunshine: Tools help docs track payments

By

With a new era of transparency for doctors and life science manufacturers kicking off today, here's how some organizations are keeping physicians informed.

Doctors could use more info on health exchanges: study

By

A new survey of doctors reveals how much they know (or don't) about the looming launch of healthcare exchanges.

Medscape looks to fill docs' diabetes-testing gap

By

A CME activity was associated with increased testing that could head off neuropathy in patients with type 2 diabetes.

Business briefs: Medscape, Livestrong, ACA, Lilly

Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results

Impact and importance of patient preference still TBD

By

JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.

Pharmas dial back reprints spend, floor it on digital to reach HCPs

Pharmas dial back reprints spend, floor it on digital to reach HCPs

By

Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.

Studies show cost doesn't drive everything

By

Two studies show that it's not enough to focus on cost to alter healthcare.

CMS releases "Sunshine" final rule: federal preemption, August start date

CMS releases "Sunshine" final rule: federal preemption, August start date

By

CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.

Pradaxa dominates doc poll of most effective journal ads

Pradaxa dominates doc poll of most effective journal ads

By

The most effective journal ads of the year included executions for Pradaxa, Humira and Conceptus' Essure Procedure, according to the Doctors' Choice Study.

Studies point to a need for better physician-patient communication

By

An adherence study found that when doctors laid out the whys and hows of prescribed medications, patients were more likely to take them. Other reports suggest that the communication gap is about more than the medication— including such factors as pricing, a desire for control, and undisclosed medical information.

Docs cozy up to brands that bring unique benefits, thought-leader backing

Docs cozy up to brands that bring unique benefits, thought-leader backing

By

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.

Study finds personal profiles can have professional implications

By

A recent paper shows licensing boards may take action for a professional's behavior regardless of whether it is in the context of a professional setting.

Congress spares pharmas from going over another cliff—for now

Congress spares pharmas from going over another cliff—for now

By

For the drug industry, the big news in the "fiscal cliff" deal is that the next big congressional showdown—one that could have big implications for the healthcare industries—has been kicked down the road a couple months.

M3 Group extends reach in Iberian and Latin American markets with partnership

M3 Group extends reach in Iberian and Latin American markets with partnership

By

MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.

Most docs don't know about FDA's opioid safety plan: survey

By

Only 35% of physicians are aware of the FDA's class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.

"Digital divide" between old and young docs narrowing, survey finds

By

Three out of five doctors are now using technology to better communicate with patients, a MedPage Today survey has found, and two-fifths say patients are generally more informed than they were five years ago.

Docs trust ED drugs above all, go with their emotions when prescribing

Docs trust ED drugs above all, go with their emotions when prescribing

By

Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.

Sermo looks for new leaders—and profitability

Sermo looks for new leaders—and profitability

By

Sermo is searching for a CEO and a medical advisory board since the physician online community's founder, Dr. Daniel Palestrant, and chief medical officer, Dr. Adam Sharp, left in November to launch a new startup called Par8o.

Firms link to cover digital doctor research front

Firms link to cover digital doctor research front

By

Two powers of the marketing research arena—Epocrates and M3—partnered today to create what they claim is the world's largest verified physician and healthcare provider panel.

CME exerts highest influence on docs' intent to Rx: survey

By

A new survey shows certified CME bested dinner meetings, mailings and even sales rep visits in one promotional measure.

Sales reps say medical knowledge, business acumen are keys to access

By

A large survey of sales reps found that knowledge of evidence-based medicine and clinical practice guidelines, as well as information related to managing the business aspects of a healthcare practice, are the two best ways to get a foot in the door with physicians

iRep lets docs sign an iPad for samples

iRep lets docs sign an iPad for samples

By

Sales reps armed with an iPad can collect digital signatures for samples thanks to iRep, a physician detailing application set to launch in mid-February.

At work, Sermo docs prefer the Epocrates app, MM&M poll finds

By

Doctors responding to an MM&M survey hosted by Sermo - a social network for practicing physicians - said they use the Epocrates mobile app more often for work purposes than any other app.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters